DET has been demonstrated to induce intrinsic apoptosis in many types of cancer cell lines, including human osteosarcoma, pancreatic cancer, cervical cancer, breast cancer, lung cancer, nasopharyngeal cancer, colorectal cancer, and liver cancer cell lines through Bcl-2 family protein modulation. Here, BCL2 is linked to osteosarcoma.